2008
DOI: 10.1016/j.intimp.2008.01.036
|View full text |Cite
|
Sign up to set email alerts
|

Validation of murine dextran sulfate sodium-induced colitis using four therapeutic agents for human inflammatory bowel disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

8
119
0
4

Year Published

2009
2009
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 176 publications
(132 citation statements)
references
References 37 publications
8
119
0
4
Order By: Relevance
“…The use of DSS to induce ulcerative colitis in mice has been widely documented (29) and the model is considered clinically and histologically reminiscent of human UC (19,29). The possibility that the DSS effects observed in intestinal conditional Flvcr1a-null mice are due to an enhanced permeability of their mucosa to this toxic compound is unlikely.…”
Section: Flvcr1a Depletion Impairs Mice Survival To Ulcerative Colitismentioning
confidence: 99%
See 1 more Smart Citation
“…The use of DSS to induce ulcerative colitis in mice has been widely documented (29) and the model is considered clinically and histologically reminiscent of human UC (19,29). The possibility that the DSS effects observed in intestinal conditional Flvcr1a-null mice are due to an enhanced permeability of their mucosa to this toxic compound is unlikely.…”
Section: Flvcr1a Depletion Impairs Mice Survival To Ulcerative Colitismentioning
confidence: 99%
“…The remaining animals were administered tap water for nine additional days and sacrified at day 17. Colon-rectum sections were stained with H&E. Damage scores on colon-rectum slides were assigned in a blinded fashion, on an scale of 0 to 6, as reported previously (19), where 0 = no signs of damage; 1 = few inflammatory cells, no signs of epithelial degeneration; 2 = mild inflammation, few signs of epithelial degeneration; 3 = moderate inflammation, few epithelial ulcerations; 4 = moderate to severe inflammation, ulcerations in more than 25% of the tissue section; 5 = moderate to severe inflammation, large ulcerations of more than 50% of the tissue section; 6 = severe inflammation and ulcerations of more than 75% of the tissue section.…”
Section: Induction Of Colitismentioning
confidence: 99%
“…In preclinical models of IBD, this can be challenging as the number of clinically validated therapies is relatively low and the number of models that respond to these therapies is also low. Although they are not typically used in the clinic due to safety issues, high-dose immunosuppressants can be used in most inflammation-mediated models as a positive control (Hoshino et al 1992;Melgar et al 2008;Hirano and Kudo 2009;McNamee et al 2010McNamee et al , 2013. In Table 1, we summarize the standard controls used in various animal models and their respective effects on disease.…”
Section: Treatment Controlsmentioning
confidence: 99%
“…Consquently, a drug maybe effective in one, but ineffective in other model of intestinal inflammation depending on its mechanism of action (Park et al 2004). Moreover, although DSS-induced colitis is one of the most widely used IBD models, due to the convenient induction, defined onset of intestinal inflammation, and its relevance for the translation of animal data to human IBD (Melgar et al 2008), even the clinically widely used, effective drugs, such as olsalazine, budesonide or methotrexate have had variable positive effects in this model, depending on several factors (concentration of DSS and 19 duration of exposure, route of drug administration, genetic background of animals, etc.) (see e.g.…”
Section: Discussionmentioning
confidence: 99%